BERLIN October 17, 2025 – Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival ...
In EGFR-mutated non-small cell lung cancer Tagrisso with pemetrexed and chemotherapy was associated with an improvement in survival. Clinical trial results have shown that among patients with locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback